<DOC>
	<DOCNO>NCT00968045</DOCNO>
	<brief_summary>The study hypothesis prophylactic fibrinogen infusion reduces postoperative bleed transfusion requirement coronary artery bypass surgery ( CABG ) patient endogenous fibrinogen level low normal range . 60 patient include prospective , randomized double-blind placebo-controlled single center study .</brief_summary>
	<brief_title>Fibrinogen Bleeding After Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<criteria>Males Females Age 18 year Patients eligible firsttime coronary artery bypass ( CABG ) surgery preoperative fibrinogen plasma concentration 3,8 g/L Signed informed consent participate study Patients undergo redo surgery Clinical laboratory sign bleed disorder Clinical laboratory sign significant liver disease , , significant disease condition investigator judgment interfere hemostasis Any medication agent may interfere hemostasis within 14 day prior study start . Clopidogrel warfarin withdrawn least 24 hour surgery . Oral aspirin allow comedication . Administration investigational drug within eight week precede preentry examination Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Fibrinogen</keyword>
	<keyword>Postoperative bleeding</keyword>
	<keyword>Transfusions</keyword>
	<keyword>CABG</keyword>
</DOC>